BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7543845)

  • 1. Effect of an equal volume replacement with 500 mL 6% hydroxyethyl starch on the blood and plasma volume of healthy volunteers.
    Mortelmans Y; Merckx E; van Nerom C; Verbruggen A; van Aken H; de Roo M; Mortelmans L
    Eur J Anaesthesiol; 1995 May; 12(3):259-64. PubMed ID: 7543845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
    Haller M; Brechtelsbauer H; Akbulut C; Fett W; Briegel J; Finsterer U
    Infusionsther Transfusionsmed; 1995 Apr; 22(2):74-80. PubMed ID: 7540445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of volume loading with 1 liter intravenous infusions of 0.9% saline, 4% succinylated gelatine (Gelofusine) and 6% hydroxyethyl starch (Voluven) on blood volume and endocrine responses: a randomized, three-way crossover study in healthy volunteers.
    Lobo DN; Stanga Z; Aloysius MM; Wicks C; Nunes QM; Ingram KL; Risch L; Allison SP
    Crit Care Med; 2010 Feb; 38(2):464-70. PubMed ID: 19789444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of colloidal volume replacement solution 6% HES 40/0.5].
    Halmágyi M
    Anaesthesist; 1984 Feb; 33(2):73-81. PubMed ID: 6201084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Degree of substitution and volume expanding effect of various medium molecular weight hydroxyethyl starch solutions].
    Kröll W; Pölz W; Colombo T; Steindorfer P
    Wien Klin Wochenschr; 1994; 106(13):416-21. PubMed ID: 7522379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hemorheologic, micro- and macrocirculatory effects of hypervolemic hemodilution with middle molecular weight hydroxyethyl starch (Haes 200/0.62; 6 percent)].
    Jung F; Waldhausen P; Spitzer S; Mrowietz C; Häuser B; Wenzel E
    Infusionstherapie; 1988 Dec; 15(6):265-71. PubMed ID: 2466797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of volume substitutes 5 percent human albumin and 6 percent hydroxyethyl starch (40,000/0.5) in pediatric anesthesia].
    Hausdörfer J; Hagemann H; Heine J
    Anasth Intensivther Notfallmed; 1986 Jun; 21(3):137-42. PubMed ID: 2428266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hydroxyethyl starch as plasma substitute: experiments in isovolamic haemodilution (author's transl)].
    Jesch F; Klövekorn WP; Sunder-Plassmann L; Seifert J; Messmer K
    Anaesthesist; 1975 May; 24(5):202-9. PubMed ID: 56900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactated Ringer's solution versus hydroxyethyl starch for volume replacement in autologous blood donors with cardiovascular disease: a controlled, randomized trial.
    Kasper SM; Dahlmann H; Mellinghoff H; Ellering J; Baumann M; Buzello W
    Vox Sang; 1998; 75(1):26-31. PubMed ID: 9745150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative study of the modification of blood, blood coagulation, cardiovascular circulation by 3% modified, fluid gelatins and 6% low-molecular weight hydroxyethyl starch].
    Hopf HB; Siepmann HP
    Infusionsther Klin Ernahr; 1987 Apr; 14 Suppl 2():31-5. PubMed ID: 2439456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolaemia in volunteers.
    James MF; Latoo MY; Mythen MG; Mutch M; Michaelis C; Roche AM; Burdett E
    Anaesthesia; 2004 Aug; 59(8):738-42. PubMed ID: 15270962
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers].
    Jung F; Koscielny J; Mrowietz C; Förster H; Schimetta W; Kiesewetter H; Wenzel E
    Arzneimittelforschung; 1993 Feb; 43(2):99-105. PubMed ID: 7681289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
    Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
    Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hemorheologic and circulatory effects of hemodilution with medium molecular weight hydroxyethyl starch in two concentrations (HAES 200/0.62 10% and 6%)].
    Jung F; Waldhausen P; Spitzer S; Wenzel E
    Acta Med Austriaca; 1991; 18 Suppl 1():9-15. PubMed ID: 1719736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hemorheologic, micro- and macrocirculatory effects of an infusion of 500 ml of 6% medium molecular weight hydroxyethyl starch (Haes 200,000/0.5)].
    Jung F; Waldhausen P; Mrowietz C; Spitzer S; Kiesewetter H; Wenzel E
    Infusionstherapie; 1989 Aug; 16(4):148-54. PubMed ID: 2478482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch.
    Gandhi SD; Weiskopf RB; Jungheinrich C; Koorn R; Miller D; Shangraw RE; Prough DS; Baus D; Bepperling F; Warltier DC
    Anesthesiology; 2007 Jun; 106(6):1120-7. PubMed ID: 17525586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
    Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
    Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma volume expansion by medium molecular weight hydroxyethyl starch in neonates: a pilot study.
    Liet JM; Bellouin AS; Boscher C; Lejus C; Rozé JC
    Pediatr Crit Care Med; 2003 Jul; 4(3):305-7. PubMed ID: 12831411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
    Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
    Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.